• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

What role will Unix play in PACS market?

Article

What role will Unix play in PACS market?A lot of ink has flowed lately in this and many other publications detailing the inroads Windows NT has made in PACS. Vendors moving to NT as their PACS operating system have cited the lower cost of

What role will Unix play in PACS market?

A lot of ink has flowed lately in this and many other publications detailing the inroads Windows NT has made in PACS. Vendors moving to NT as their PACS operating system have cited the lower cost of software based on the Microsoft platform, as well as perceived better interoperability with other healthcare information systems, as the rationale behind their decision.

Of course, the gains of NT have come primarily at the expense of Unix-based systems, which are either being thrust into a complementary role in PACS networks or are being discarded altogether. To counteract this trend, Unix developers are actively looking to improve their competitive position with NT. One example is Sun Microsystems' debut of a line of inexpensive Unix-based workstations, as well as a new family of storage offerings (PNN 2/98). Sun has targeted medical imaging and PACS as key market segments for its new product introductions.

Will these moves be enough to reverse NT's gains, or at least secure a tenable competitive position for Unix in PACS? It's too early to tell, of course. But indications are that this will be a tricky proposition. While Sun's move to release low-cost, Unix-based systems is a smart one and will score points with its PACS vendors, hospital IT departments are increasingly demanding systems based on NT. With the era of integrated image and information systems looming on the horizon, PACS purchasing decisions are no longer made solely on the basis of the technology's benefits to the radiology department.

-By Erik L. Ridley, Editor

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.